Hackensack Meridian Health clinical trial pipeline

5 trials changed in the last 30 days: 2 stopped, 2 with notable changes, 1 with a minor change only.

1. Stopped

   G360-IIT · Immune Profile Selection By Fraction of ctDNA…G360-IIT · Immune Profile Selection By Fraction of ctDNA · Advanced NSCLC Treated With Immunotherapy

   Trial terminated

   Sponsor's reason: Slow Accrual

   Also in this update: Final enrollment: 5 participants — 5% of the 108 planned; Primary completion date changed from estimate of Apr 28, 2027 to Aug 13, 2026

   Hackensack Meridian Health·Phase 2· NCT05715229· Registry history of NCT05715229 on ClinicalTrials.gov (opens the registry)

   Updated Sep 23, 2026

2. Stopped

   Transitions of Care Clinic (TOCC)

   Trial terminated

   Sponsor's reason: Funding restrains

   Also in this update: Final enrollment: 69 participants (planned 150); Primary completion date changed from estimate of Apr 15, 2027 to Sep 7, 2026

   Hackensack Meridian Health·Not applicable· NCT06937827· Registry history of NCT06937827 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

3. Notable

   Selinexor, in Combination With Carfilzomib, Daratumumab or…Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide · Multiple Myeloma

   Primary and study completion pushed from Feb 2027 to Feb 2028

   Also in this update: Recruitment resumed after suspension

   Hackensack Meridian Health·Phase 2· NCT04661137· Registry history of NCT04661137 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

4. Notable

   CarMob · Carfilzomib Based Chemotherapy Mobilization for…CarMob · Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

   Primary and study completion pushed from Sep 2026 to Aug 2027

   Hackensack Meridian Health·Phase 1· NCT03909412· Registry history of NCT03909412 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.